Mersana Therapeutics, Inc. Contract with Customer, Liability, Noncurrent
Mersana Therapeutics, Inc. had Contract with Customer, Liability, Noncurrent of $78.95 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2025-11-14
- 2025-09-30: Contract with Customer, Liability, Noncurrent $78.95M.
- 2025-06-30: Contract with Customer, Liability, Noncurrent $78.38M.
- 2025-03-31: Contract with Customer, Liability, Noncurrent $77.02M.
- 2024-12-31: Contract with Customer, Liability, Noncurrent $79.46M.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2025-09-30 | $78.95M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $78.38M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $77.02M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $79.46M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $83.86M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $87.57M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $92.02M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $97.17M 10-K · filed 2025-03-03 |
| 2023-09-30 | $111.50M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $114.20M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $115.58M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $117.04M 10-K · filed 2024-02-28 |
| 2022-09-30 | $101.42M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $11.68M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $25.62M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2018-09-30 | $32.76M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $28.98M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $29.56M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $28.77M 10-K · filed 2019-03-08 |